Product Name: FOXO4-DRI
Trade nomen:Prokhofim
Formulae hypotheticae: C228H388N86O64
M. Pondus: 5358.05 g / mol
Specification: 1mg/Vials
Puritas : 98% HPLC
Aspectus: White Lyophilized pulveris
Typical usus:Anti-canus pondus damnum
Latin Packing : 10phialas / rhoncus
Shelf Life:6 Mensis
Repono:Locus temperatus a lumine
Foxo4-dri, FOXO4 D-Retro-Inverso peptide, et quae Proxofim, primum relatum est in 'Targeted Apoptosis Cellulae Senescentium Restituo TEXTUS Homeostasis in Responsione Chemotoxicity et Aging' a Baar et al.
FOXO4 DRI peptide comprehendens amino acidi seriei: LTLRKEPASEIAQSILEAYSQNGWANRRSGGKRP, in quibus amino acidorum in dicto amino acidi seriei sunt residua acidum D-amino. FOXO4 D-Retro-Inverso peptide selectively induces apoptosis of senescent cells reverses effects of chemotoxicity and aging in mice.
FOXO4-DRI is a synthetic version of FOXO4, which contains D amino acids instead of L amino acids. This modification allows it to retain the functionality of the original protein and longer shelf life, and lower clearance from the body. Its most prominent function is the regulation of apoptosis in senescent cells. It inhibits FOXO4-p53 binding. Thus p53 can target pro-apoptotic genes and promote their expression. These proteins, rursus, bring about apoptosis of old cells, thereby reducing the old cell burden in tissues. This increases cellular differentiation and tissue repair,
and regrowth and decrease in “biological age.”
FOXO4 notum est adiuvare perpetuationem cellularum seniorum vel senescentium. Ligat ad p53 et per hoc impedit apoptoticam mortem cellularum senescentium. DRI peptide impedit FOXO4-p53 commercium.
FOXO4 DRI peptide comprehendens amino acidi seriei: LTLRKEPASEIAQSILEAYSQNGWANRRSGGKRP, in quibus amino acidorum in dicto amino acidi seriei sunt residua acidum D-amino. FOXO4 D-Retro-Inverso peptide selectively induces apoptosis of senescent cells reverses effects of chemotoxicity and aging in mice